We assign a fundamental rating of 1 out of 10 to CKPT. CKPT was compared to 525 industry peers in the Biotechnology industry. Both the profitability and financial health of CKPT have multiple concerns. CKPT has a correct valuation and a medium growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CKPT has reported negative net income.
In the past year CKPT has reported a negative cash flow from operations.
CKPT had negative earnings in each of the past 5 years.
CKPT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -752.78%, CKPT is not doing good in the industry: 97.67% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-752.78%
ROE	N/A
ROIC	N/A

ROA(3y)-729.34%

ROA(5y)-468.78%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CKPT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for CKPT has been increased compared to 1 year ago.
CKPT has more shares outstanding than it did 5 years ago.
CKPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -85.21, we must say that CKPT is in the distress zone and has some risk of bankruptcy.
CKPT has a Altman-Z score of -85.21. This is amonst the worse of the industry: CKPT underperforms 96.42% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-85.21

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

CKPT has a Current Ratio of 0.37. This is a bad value and indicates that CKPT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CKPT (0.37) is worse than 93.74% of its industry peers.
A Quick Ratio of 0.37 indicates that CKPT may have some problems paying its short term obligations.
CKPT has a Quick ratio of 0.37. This is amonst the worse of the industry: CKPT underperforms 93.20% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.37
Quick Ratio	0.37

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.43% over the past year.
The Revenue for CKPT has decreased by -60.19% in the past year. This is quite bad
CKPT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -52.58% yearly.

EPS 1Y (TTM)53.43%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%42.42%

Revenue 1Y (TTM)-60.19%

Revenue growth 3Y-46.65%

Revenue growth 5Y-52.58%

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CKPT will show a very strong growth in Earnings Per Share. The EPS will grow by 31.84% on average per year.
The Revenue is expected to grow by 711.65% on average over the next years. This is a very strong growth

EPS Next Y87.52%

EPS Next 2Y67.51%

EPS Next 3Y85.74%

EPS Next 5Y31.84%

Revenue Next Year300659%

Revenue Next 2Y11555.7%

Revenue Next 3Y3960.1%

Revenue Next 5Y711.65%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CKPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 3.70, the valuation of CKPT can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CKPT indicates a rather cheap valuation: CKPT is cheaper than 98.57% of the companies listed in the same industry.
CKPT is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.95, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	3.7

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CKPT's earnings are expected to grow with 85.74% in the coming years.